Keywords: copd, market, set, grow, reach, 12b, increased
COPD market set to grow 9% a year to reach $12B by 2014
Article | 17 April 2006
The increased uptake of expensive maintenance therapies, including drugs from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim and Pfizer, will help drive robust 9% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
